FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter ALNYLAM PHARMS INC NDA 214103
Letter
NDA 214103
ALNYLAM PHARMS INC
FDA.report
›
FDA Drug Approvals
›
ALNYLAM PHARMS INC
›
NDA 214103
›
Letter
Application #214103
Documents
Letter
2022-10-07
Application Sponsors
NDA 214103
ALNYLAM PHARMS INC
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.